Millipore Sigma Vibrant Logo

324801 InSolution™ Epoxomicin, Synthetic - Calbiochem

InSolution™ Epoxomicin, Synthetic, is a 1 mM solution of Epoxomicin, Synthetic (Cat. No. 324800) in DMSO.

Ficha de datos de seguridad (MSDS o SDS), certificado de análisis y de calidad (CoA y CoQ), expedientes, folletos y otros documentos disponibles.

Sinónimos: Proteasome Inhibitor XIV

Primary Target: CT-L,T-L,PGPH activity of proteasome
View Products on Sigmaaldrich.com
324801
Ver precios y disponibilidad

Descripción

Replacement Information

Tabla espec. clave

Empirical Formula
C₂₈H₅₀N₄O₇

Precios y disponibilidad

Número de referencia DisponiblidadEmbalaje Cant./Env. Precio Cantidad
324801-50UG
Comprobando disponibilidad...
—
Disponibilidad a confirmar Disponibilidad a confirmar
Ingrese cantidad 
Suspendido
Cantidades limitadas disponibles
Debe confirmarse disponibilidad
    El resto: se avisará
      El resto: se avisará
      Se avisará
      Póngase en contacto con el Servicio de Atención al Cliente
      Contact Customer Service

      		 Ampolla de plást. 50 μg
      Recuperando precio...
      No pudo obtenerse el precio
      La cantidad mínima tiene que ser múltiplo de
      Maximum Quantity is
      Al finalizar el pedido Más información
      Ahorró ()
       
      —
      Solicitar precio
      		 —
      Description
      Catalogue Number324801
      Brand Family Calbiochem®
      SynonymsProteasome Inhibitor XIV
      References
      ReferencesMeng, L., et al. 1999. Proc. Natl. Acad. Sci. USA 96, 10403.
      Sin, N., et al. 1999. Bioorg. Med. Chem. Lett. 9, 2283.
      Hanada, M., et al. 1992. J. Antibiot. 45, 1746.
      Product Information
      ATP CompetitiveN
      FormLiquid
      FormulationA 1 mM (50 µg/90 µl) solution of Epoxomicin, Synthetic (Cat. No. 324800) in DMSO.
      Hill FormulaC₂₈H₅₀N₄O₇
      Chemical formulaC₂₈H₅₀N₄O₇
      Hygroscopic Hygroscopic
      ReversibleN
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetCT-L,T-L,PGPH activity of proteasome
      Purity≥95% by HPLC
      Physicochemical Information
      Cell permeableN
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Shipped with Blue Ice or with Dry Ice
      Toxicity Irritant
      Storage -20°C
      Protect from Light Protect from light
      Hygroscopic Hygroscopic
      Do not freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot and freeze (-20°C).
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Número de referencia GTIN
      324801-50UG 04055977216165

      Documentation

      Licencias necesarias

      Título
      PRODUCTO REGULADO POR LA SECRETARÍA DE SALUD

      InSolution™ Epoxomicin, Synthetic - Calbiochem Ficha datos de seguridad (MSDS)

      Título

      Ficha técnica de seguridad del material (MSDS) 

      InSolution™ Epoxomicin, Synthetic - Calbiochem Certificados de análisis

      CargoNúmero de lote
      324801

      Referencias bibliográficas

      Visión general referencias
      Meng, L., et al. 1999. Proc. Natl. Acad. Sci. USA 96, 10403.
      Sin, N., et al. 1999. Bioorg. Med. Chem. Lett. 9, 2283.
      Hanada, M., et al. 1992. J. Antibiot. 45, 1746.
      Ficha técnica

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision20-June-2008 RFH
      SynonymsProteasome Inhibitor XIV
      DescriptionAn antitumor agent of microbial origin that acts as a potent, highly specific, and irreversible inhibitor of chymotrypsin-like (CT-L), trypsin-like (T-L), and peptidylglutamyl peptide hydrolyzing (PGPH) activities of the proteasome. Modifies the proteasomal catalytic subunits LMP-7, MECL1, and Z. Epoxomicin also displays potent anti-inflammatory activity in vivo.
      FormLiquid
      FormulationA 1 mM (50 µg/90 µl) solution of Epoxomicin, Synthetic (Cat. No. 324800) in DMSO.
      Intert gas (Yes/No) Packaged under inert gas
      Chemical formulaC₂₈H₅₀N₄O₇
      Structure formulaStructure formula
      Purity≥95% by HPLC
      Storage Protect from light
      -20°C
      Hygroscopic
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot and freeze (-20°C).
      Toxicity Irritant
      ReferencesMeng, L., et al. 1999. Proc. Natl. Acad. Sci. USA 96, 10403.
      Sin, N., et al. 1999. Bioorg. Med. Chem. Lett. 9, 2283.
      Hanada, M., et al. 1992. J. Antibiot. 45, 1746.